Pfizer's Neurontin Marketing Hurt Payors, 1st Circ. Hears
Blue Cross Blue Shield of Louisiana and other third-party payors struck back at Pfizer Inc. on Tuesday in their bid to return their case to multidistrict litigation over alleged off-label marketing...To view the full article, register now.
Already a subscriber? Click here to view full article